It is stated exactly as this, from the Oct 5th PR:
"The statisticians will proceed as quickly as possible with analyses of the raw data and prepare summaries of the Trial results for review by the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts, who will analyze the data with the statisticians in preparation for public announcement and scientific publication."
To me, sounds like OUR team (Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts) will work with THEIR team (independent statisticians) once company is unblinded.
That could be happening as we speak. Topline PR followed by Journal publication. Those are the tea leaves I am reading from DI saying "reread the Oct.5th PR"